New gadget boosts fluid removal for kidney patients on home dialysis

NCT ID NCT05874804

Completed Disease control Sponsor: Triomed AB Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a device called Carry Life UF in 28 adults with end-stage kidney disease who use continuous ambulatory peritoneal dialysis (CAPD) at home. The device adds glucose to the dialysis fluid already in the belly to help remove more fluid over a 5-hour session. Researchers compared how much fluid was removed with the device versus a standard high-glucose dialysis bag. The goal was to see if the device could improve fluid removal without increasing side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Carry Life UF device
What this could lead to: If successful, this device could help kidney dialysis patients remove more fluid during treatment, potentially improving fluid balance without needing stronger dialysis solutions.
What could go wrong: This was a small, early-stage study with only 28 participants. The device adds complexity to standard dialysis, and long-term safety or benefit is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

END-STAGE RENAL DISEASE

Contacts and locations

Locations

ASST-Cremona

Cremona, Italy
Heartlands Hospital

Birmingham, United Kingdom
Karolinska Universitetssjukhuset, Njurmedicin Rosenlund

Stockholm, Sweden
King's College Hospital

London, United Kingdom
London Royal Hospital, Barth Health NHS Trust

London, United Kingdom
Nottingham University Hospitals NHS Trust

Nottingham, United Kingdom
Polyclinic Milan

Milan, Italy
Queen Elisabeth's Hospital

Birmingham, United Kingdom
Royal Free London NHS Foundation Trust

London, United Kingdom
Sahlgrenska Universitetssjukhuset

Gothenburg, Sweden
Skånes University Hospital

Lund, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.